PLEASANTON, CA.—10x Genomics, Inc., a company focused on accelerating genomic discovery, today announced that BioLegend and Immudex will be the first 10x Compatible Partnersproviding products for its new single cell Feature Barcoding Technology, which was revealed at the 2018 Advances in Genome Biology and Technology meeting in February this year. The resulting product innovations, available at the end of 2018, will […]
HERCULES, Calif.–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of a range of recombinant monoclonal anti-ranibizumab antibodies that are highly specific for the monoclonal antibody drug ranibizumab (Lucentis) or the complex of ranibizumab with its target, vascular endothelial growth factor A […]
Agreement to provide Dynex instruments through ZEUS’ sales channels CHANTILLY, Va.–Dynex® Technologies announced today it has finalized a supply agreement with ZEUS Scientific (Branchburg, NJ) enabling ZEUS to sell Dynex instruments to the global clinical market. This new direct partnership builds on the long standing relationship between both companies with Dynex Technologies’ industry proven DS2®, DSX® and […]
Agreement to provide Dynex instruments through ZEUS’ sales channels CHANTILLY, Va.–Dynex® Technologies announced today it has finalized a supply agreement with ZEUS Scientific (Branchburg, NJ) enabling ZEUS to sell Dynex instruments to the global clinical market. This new direct partnership builds on the long standing relationship between both companies with Dynex Technologies’ industry proven DS2®, DSX® and […]
BD® AbSeq Assay Enables Deeper Understanding of Role Individual Cells Play in the Immune System FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the commercial release of the BD® AbSeq assay to analyze protein expression at the single-cell level using high-throughput sequencing. The assay brings together high-quality antibodies from […]
Wakefield, MA – Protein Dynamic Solutions LLC (PDS), developer of breakthrough technologies for biopharmaceutical characterization of therapeutic proteins, announces the appointment of Dr. Selena Larkin to its leadership team. PDS’ flagship product is a high-throughput drug developability and comparability assessment tool, ProteinMentorTM, which uses a unique combination of laser-microscopy and molecular spectrometry to determine aggregate size […]
MINNEAPOLIS — Bio-Techne again disrupts protein analysis technology with the introduction of the newest member of their ProteinSimple-branded Simple Western family, Jess. This evolutionary technology simplifies protein expression analysis, while speeding up time to result. Jess automates both the protein separation and immunodetection elements characteristic of traditional protein analysis techniques, eliminating many of the tedious, error-prone steps. […]
MONTREAL’S MÉDIMABS TO DISTRIBUTE REAGENT ANTIBODIES TO INTERNATIONAL MARKET Toronto, ON, Canada – The Centre for the Commercialization of Antibodies and Biologics (CCAB) and MédiMabs Antibodies have signed an agreement for the distribution of CCAB’s reagent antibodies. The agreement marks the launch of a new business segment for CCAB and allows MédiMabs to expand its portfolio to include human synthetic […]
Combining the world-leading proteomic and artificial intelligence/machine learning technologies to produce novel, actionable health insights across many diseases, conditions and markets SomaLogic and GNS Healthcare announced today that SomaLogic has obtained a license to apply GNS Healthcare’s proprietary REFS™ (Reverse Engineering & Forward Simulation) causal machine learning technology to SomaLogic’s proprietary SOMAscan®-derived protein data sets. […]
SAN FRANCISCO — Enable Biosciences Inc was awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase II grant for $750,000 to commercialize ultrasensitive and multiplexable immunoassays for both research and clinical diagnostic use. Over 70% of clinical decisions are informed by lab tests, many of which rely on detecting antibody biomarkers. “For hundreds of infectious and autoimmune diseases and cancer, early […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
